Lingshu Wang

Best Publications

• SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness.

  Kizzmekia S. Corbett;Darin K. Edwards;Sarah R. Leist;Olubukola M. Abiona

  1589
  Citations

• Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen

  Jesper Pallesen;Nianshuang Wang;Kizzmekia S. Corbett;Daniel Wrapp

  1137
  Citations

• Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates.

  Kizzmekia S Corbett;Barbara Flynn;Kathryn E Foulds;Joseph R Francica

  1112
  Citations

• Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies

  Masaru Kanekiyo;Chih Jen Wei;Hadi M. Yassine;Patrick M. McTamney;Patrick M. McTamney

  936
  Citations

• Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection

  Hadi M. Yassine;Jeffrey C. Boyington;Patrick M. McTamney;Patrick M. McTamney;Chih Jen Wei;Chih Jen Wei

  749
  Citations

• LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

  Unknown

  718
  Citations

• Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants.

  Pegu, Amarendra, O’Connell, Sarah E.;Stephen D. Schmidt;O’Dell, Sijy, Talana, Chloe A.

  550
  Citations

• The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates.

  Bryan E. Jones;Patricia L. Brown-Augsburger;Kizzmekia S. Corbett;Kathryn Westendorf

  429
  Citations

• Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge

  Daphne A Stanley;Anna N Honko;Anna N Honko;Clement Asiedu;John C Trefry

  409
  Citations

• Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses

  M. Gordon Joyce;Adam K. Wheatley;Paul V. Thomas;Gwo-Yu Chuang

  349
  Citations

• mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron

  Unknown

  346
  Citations

• Evaluation of candidate vaccine approaches for MERS-CoV

  Lingshu Wang;Wei Shi;M. Gordon Joyce;Kayvon Modjarrad

  324
  Citations

• Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination

  Jiwon Lee;Daniel R. Boutz;Veronika Chromikova;M. Gordon Joyce

  313
  Citations

• Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates.

  Kizzmekia S. Corbett;Martha C. Nason;Britta Flach;Matthew Gagne

  285
  Citations

• Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529

  Unknown

  280
  Citations

• Broadly neutralizing antibodies target the coronavirus fusion peptide

  Unknown

  266
  Citations

• Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor Repertoires.

  Ming Tian;Ming Tian;Cheng Cheng;Xuejun Chen;Hongying Duan

  252
  Citations

• Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape.

  Lingshu Wang;Wei Shi;James D. Chappell;M. Gordon Joyce

  227
  Citations

• Trypsin treatment unlocks barrier for zoonotic bat coronavirus infection

  Vineet D. Menachery;Vineet D. Menachery;Kenneth H. Dinnon;Boyd L. Yount;Eileen T. McAnarney;Eileen T. McAnarney

  217
  Citations

• Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants.

  Lingshu Wang;Tongqing Zhou;Yi Zhang;Eun Sung Yang

  186
  Citations